The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavigne, L. M.
Right arrow Articles by Sypek, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavigne, L. M.
Right arrow Articles by Sypek, J. P.
The Journal of Immunology, 1998, 160: 284-292.
Copyright © 1998 by The American Association of Immunologists

The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection

Liz M. Lavigne, Lisa R. Schopf, Charles L. Chung, Rich Maylor and Joseph P. Sypek1

Department of Preclinical Research and Development, Genetics Institute, Inc., Andover, MA 01810

Studies on murine candidiasis suggest that resistance to disease is linked to a Th1 response and production of IFN-{gamma}, while failure to elicit protection is associated with a Th2 response and production of IL-4 and IL-10. Experimental infection of C57BL/6 mice, IL-12 treatment of these mice, or both infection and IL-12 treatment resulted in a characteristic Th1 cytokine mRNA profile as measured by quantitative competitive PCR. Specifically, little or no IL-4 transcripts were detected, while IFN-{gamma} message was elevated, particularly with IL-12 treatment. Despite its role in driving increased IFN-{gamma} expression and production, IL-12 treatment, paradoxically, promoted disease progression in our model. Therefore, we examined the effect of IFN-{gamma} neutralization on IL-12-induced susceptibility to infection. None of the systemically infected mice receiving IL-12 alone survived, while IL-12- and anti-IFN-{gamma}-treated mice had a 70% survival rate, similar to that after infection alone. These results suggested that IFN-{gamma} induced by IL-12 treatment contributed to lethality. However, in separate studies, IFN-{gamma} knockout mice were more susceptible to infection than their wild-type counterparts, suggesting that IFN-{gamma} is required for resistance. Nonetheless, infected IFN-{gamma} knockout mice treated with recombinant murine IL-12 exhibited enhanced resistance, suggesting that the toxicities observed with IL-12 are directly attributable to IFN-{gamma} and that an optimal immune response to Candida infections necessitates a finely tuned balance of IFN-{gamma} production. Thus, we propose that although IFN-{gamma} can drive resistance, the overproduction of IFN-{gamma} during candidiasis, mediated by IL-12 administration, leads to enhanced susceptibility.




This article has been cited by other articles:


Home page
IOVSHome page
J. Hu, Y. Wang, and L. Xie
Potential Role of Macrophages in Experimental Keratomycosis
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2087 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Ito, J. Pedras-Vasconcelos, and D. M. Klinman
CpG Oligodeoxynucleotides Increase the Susceptibility of Normal Mice to Infection by Candida albicans
Infect. Immun., September 1, 2005; 73(9): 6154 - 6156.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Lindell, T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle
Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection
J. Immunol., June 15, 2005; 174(12): 7920 - 7928.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bozza, F. Fallarino, L. Pitzurra, T. Zelante, C. Montagnoli, S. Bellocchio, P. Mosci, C. Vacca, P. Puccetti, and L. Romani
A Crucial Role for Tryptophan Catabolism at the Host/Candida albicans Interface
J. Immunol., March 1, 2005; 174(5): 2910 - 2918.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Zafirova, M. Yordanov, and R. Kalfin
Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection
Int. Immunol., August 1, 2004; 16(8): 1125 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn
Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair
J. Immunol., October 1, 2003; 171(7): 3655 - 3667.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Koido, Y. Tanaka, D. Chen, D. Kufe, and J. Gong
The Kinetics of In Vivo Priming of CD4 and CD8 T Cells by Dendritic/Tumor Fusion Cells in MUC1-Transgenic Mice
J. Immunol., March 1, 2002; 168(5): 2111 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Chiani, C. Bromuro, and A. Torosantucci
Defective Induction of Interleukin-12 in Human Monocytes by Germ-Tube Forms of Candida albicans
Infect. Immun., October 1, 2000; 68(10): 5628 - 5634.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Elahi, G. Pang, R. Clancy, and R. B. Ashman
Cellular and Cytokine Correlates of Mucosal Protection in Murine Model of Oral Candidiasis
Infect. Immun., October 1, 2000; 68(10): 5771 - 5777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.